MedTrace Logo

Parathyroid Hormone for the Treatment of Humerus Fractures

NCT01687374 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2012-09-18

No results posted yet for this study

Summary

Hypothesis:

The investigators want to study whether parathyroid hormone improves healing of humerus after a fracture. The investigators will assess healing of the humerus with Constant score.

Conditions

  • Shoulder Fractures

Interventions

DRUG

1-84 parathyroid hormone

100 micrograms of 1-84 parathyroid hormone daily for 8 weeks, subcutaneous injection.

DRUG

Placebo

Saline injection daily for 8 weeks.

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • Hvidovre University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-12-31
Completion
2013-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01687374 on ClinicalTrials.gov